Adipokines (leptin, resistin and visfatin) could serve as a missing link in the causal relationship between psoriasis and comorbidities and may provide a biomarker for disease severity such as obesity and diabetes, risk of comorbidities and treatment success. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.